Cynata Therapeutics Ltd

ASX:CYP (Australia)  
A$ 0.19 (0%) Apr 12
At Loss
P/B:
2.72
Market Cap:
A$ 33.23M ($ 21.56M)
Enterprise V:
A$ 22.07M ($ 14.32M)
Volume:
17.00K
Avg Vol (2M):
166.32K
Also Trade In:
Volume:
17.00K
At Loss
Avg Vol (2M):
166.32K

Business Description

Description
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.91
Interest Coverage No Debt
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 49.75
9-Day RSI 50.51
14-Day RSI 51.08
6-1 Month Momentum % 38.46
12-1 Month Momentum % -18.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.7
Quick Ratio 9.7
Cash Ratio 9.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.2
Name Current Vs Industry Vs History
ROE % -85.2
ROA % -77.28
ROIC % -678.41
ROC (Joel Greenblatt) % -4613.57
ROCE % -103.99

Financials (Next Earnings Date:2024-04-26 Est.)

ASX:CYP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cynata Therapeutics Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.087
Beta 1.05
Volatility % 70.82
14-Day RSI 51.08
14-Day ATR (A$) 0.011212
20-Day SMA (A$) 0.1825
12-1 Month Momentum % -18.18
52-Week Range (A$) 0.105 - 0.23
Shares Outstanding (Mil) 179.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cynata Therapeutics Ltd Filings

Filing Date Document Date Form
No Filing Data

Cynata Therapeutics Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Cynata Therapeutics Ltd Frequently Asked Questions

What is Cynata Therapeutics Ltd(ASX:CYP)'s stock price today?
The current price of ASX:CYP is A$0.19. The 52 week high of ASX:CYP is A$0.23 and 52 week low is A$0.11.
When is next earnings date of Cynata Therapeutics Ltd(ASX:CYP)?
The next earnings date of Cynata Therapeutics Ltd(ASX:CYP) is 2024-04-26 Est..
Does Cynata Therapeutics Ltd(ASX:CYP) pay dividends? If so, how much?
Cynata Therapeutics Ltd(ASX:CYP) does not pay dividend.

Press Release

Subject Date
No Press Release